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Background
Familial Mediterranean fever (FMF) and Crohn’s disease
(CD) are autoinflammatory disorders, associated with
genes (MEFV and NOD2/CARD15), encoding for regu-
latory proteins, important in innate immunity, apoptosis,
cytokine processing and inflammation. While mutations
in the MEFV gene were shown to modify CD, the role
of NOD2/CARD 15 gene mutations in the FMF disease
phenotype was never studied before.
Methods
The cohort consisted of 103 consecutive children with
FMF, followed in a single referral center. NOD2/
CARD15 genotypes were analyzed in all patients and
299 ethnically matched unaffected controls. Demo-
graphic data, clinical characteristics and disease course
of FMF patients with and without NOD2/CARD 15
mutation were compared.
Results
A single NOD2/CARD 15 mutation was detected in 10
(9.7%) FMF patients and 26 (8.7%) of controls. No
homozygotes or compound heterozygotes were discov-
ered in the 2 groups. FMF patients carrying a NOD2/
CARD 15 mutation had higher rate of erysipelas-like
erythema and acute scrotum attacks and a trend for
higher rate of colchicine resistence and a more severe
disease as compared to patients without mutations.
Conclusion
NOD2/CARD 15 mutations are not associated with a
susceptibility to develop FMF, yet the presence of these
mutations in FMF patients appears to be associated with
a trend to a more severe disease.
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